Skip to main content
All lobbying filings

HOGAN LOVELLS US LLP

Lobbying for CABALETTA BIO · Clinical-stage biotechnology company focused on T cell therapies

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate · $20,000.00 income · posted Jul 16, 2025

Official filing document

 Lobbying activity 1
Medicare/Medicaid

Cell and gene therapy innovation and access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem